|
Market Closed -
Nasdaq
01:00:00 21/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 10.08 USD | -2.04% |
|
-11.35% | -26.96% |
| 11-10 | Janux Therapeutics, Inc. - Special Call | |
| 11-09 | Janux Reports Deep B-Cell Depletion in Initial Phase 1 Trial of JANX011; Shares Fall | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| JANX | Delayed | |
| JANX | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 13.36 | 14.58 | 14.06 |
| Spread/Res. | -24.55% | -30.86% | -28.31% |
| Spread/Supp. | +4.35% | +4.35% | +5.00% |
| Support | 9.66 | 9.66 | 9.6 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- JANX Stock
- Charts Janux Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















